Home
/
Bio Green Med Solution, Inc.
/
Financials
/
Quarterly
Bio Green Med Solution, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Bio Green Med Solution, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$0
May 14, 2018
Q1
2018
Mar 31, 2017
$0
May 14, 2018
Q3
2016
Sep 30, 2016
$205.0K
Nov 14, 2016
Q1
2017
Mar 31, 2016
$139.0K
May 12, 2017
Q3
2016
Sep 30, 2015
$715.0K
Nov 14, 2016
Q2
2015
Jun 30, 2015
$296.0K
Aug 12, 2015
Q1
2016
Mar 31, 2015
$512.0K
May 13, 2016
Q3
2015
Sep 30, 2014
$735.0K
Nov 12, 2015
Q2
2015
Jun 30, 2014
$356.0K
Aug 12, 2015
Q1
2015
Mar 31, 2014
$396.0K
May 12, 2015
Q3
2014
Sep 30, 2013
$309.0K
Nov 12, 2014
Q2
2014
Jun 30, 2013
$264.0K
Aug 12, 2014
Q1
2014
Mar 31, 2013
$212.0K
May 13, 2014
Q3
2013
Sep 30, 2012
$38.0K
Nov 14, 2013
Q2
2013
Jun 30, 2012
$26.0K
Aug 14, 2013
Q1
2012
Mar 31, 2012
$161.0K
May 15, 2012
Q3
2011
Sep 30, 2011
$164.0K
Nov 14, 2011
Q2
2012
Jun 30, 2011
$168.0K
Aug 14, 2012
Q1
2012
Mar 31, 2011
$192.0K
May 15, 2012
Q3
2011
Sep 30, 2010
$159.0K
Nov 14, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($988.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($1.32M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($1.32M)
Nov 13, 2025
Q3
2025
Mar 31, 2025
($81.0K)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($81.0K)
May 14, 2025
Q2
2025
Mar 31, 2025
($81.0K)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($1.96M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($3.26M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($3.26M)
Nov 13, 2025
Q2
2025
Mar 31, 2024
($2.95M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.95M)
May 14, 2025
Q3
2025
Mar 31, 2024
($2.95M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($6.03M)
Nov 12, 2024
Q2
2023
Jun 30, 2023
($5.45M)
Aug 14, 2024
Q3
2024
Jun 30, 2023
($5.45M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($5.80M)
May 14, 2024
Q3
2024
Mar 31, 2023
($5.80M)
Nov 12, 2024
Q2
2023
Mar 31, 2023
($5.80M)
Aug 14, 2024
Q3
2023
Sep 30, 2022
($5.10M)
Nov 29, 2023
Q2
2023
Jun 30, 2022
($4.58M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($992.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($1.32M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($5.04M)
May 14, 2025
Q3
2025
Sep 30, 2024
($2.18M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($3.64M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($4.36M)
May 14, 2025
Q3
2024
Sep 30, 2023
($6.85M)
Nov 12, 2024
Q2
2023
Jun 30, 2023
($5.93M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($7.32M)
May 14, 2024
Q3
2023
Sep 30, 2022
($6.47M)
Nov 29, 2023
Q2
2023
Jun 30, 2022
($5.79M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($6.56M)
May 11, 2023
Q3
2022
Sep 30, 2021
($6.00M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($6.10M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($4.31M)
May 12, 2022
Q3
2021
Sep 30, 2020
($2.57M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($2.47M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($2.42M)
May 14, 2021
Q3
2020
Sep 30, 2019
($2.35M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($2.34M)
Aug 13, 2020